Propofol reversed the drug resistance of docetaxel induced by hypoxia and attenuated the process of EMT via inhibition of HIF‐1α in prostate cancer cells, suggesting that propofol may help overcome prostate cancer's resistance to chemotherapy under hypoxic conditions.80 Here, HIF1A is linked to prostate carcinoma.